The U.S. Department of Justice has determined that courts that prohibit individuals from taking prescribed medication for their opioid use disorder are in violation of the Americans With Disabilities Act.

The DOJ investigation examined instances in which Pennsylvania judges enacted policies that stopped or limited people’s use of medication that help to curb opioid dependence, such as methadone, buprenorphine and naltrexone. The investigation concluded that the Pennsylvania Unified Judicial System was in violation of the Title II of the Americans With Disabilities Act. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]